278 related articles for article (PubMed ID: 37572360)
21. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011535. PubMed ID: 33871055
[TBL] [Abstract][Full Text] [Related]
22. Topical treatment for facial burns.
Hoogewerf CJ; Hop MJ; Nieuwenhuis MK; Oen IM; Middelkoop E; Van Baar ME
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD008058. PubMed ID: 32725896
[TBL] [Abstract][Full Text] [Related]
23. Oral H1 antihistamines as 'add-on' therapy to topical treatment for eczema.
Matterne U; Böhmer MM; Weisshaar E; Jupiter A; Carter B; Apfelbacher CJ
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012167. PubMed ID: 30666626
[TBL] [Abstract][Full Text] [Related]
24. Interventions for morphea.
Albuquerque JV; Andriolo BN; Vasconcellos MR; Civile VT; Lyddiatt A; Trevisani VF
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD005027. PubMed ID: 31309547
[TBL] [Abstract][Full Text] [Related]
25. Colchicine for the treatment of COVID-19.
Mikolajewska A; Fischer AL; Piechotta V; Mueller A; Metzendorf MI; Becker M; Dorando E; Pacheco RL; Martimbianco ALC; Riera R; Skoetz N; Stegemann M
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD015045. PubMed ID: 34658014
[TBL] [Abstract][Full Text] [Related]
26. Interventions for minimal change disease in adults with nephrotic syndrome.
Azukaitis K; Palmer SC; Strippoli GF; Hodson EM
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD001537. PubMed ID: 35230699
[TBL] [Abstract][Full Text] [Related]
27. Interventions for mycosis fungoides.
Valipour A; Jäger M; Wu P; Schmitt J; Bunch C; Weberschock T
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD008946. PubMed ID: 32632956
[TBL] [Abstract][Full Text] [Related]
28. Interventions for postburn pruritus.
Sinha S; Gabriel VA; Arora RK; Shin W; Scott J; Bharadia SK; Verly M; Rahmani WM; Nickerson DA; Fraulin FO; Chatterjee P; Ahuja RB; Biernaskie JA
Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013468. PubMed ID: 38837237
[TBL] [Abstract][Full Text] [Related]
29. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.
Reis S; Metzendorf MI; Kuehn R; Popp M; Gagyor I; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2023 Nov; 11(11):CD015395. PubMed ID: 38032024
[TBL] [Abstract][Full Text] [Related]
30. Topical treatments for scalp psoriasis.
Schlager JG; Rosumeck S; Werner RN; Jacobs A; Schmitt J; Schlager C; Nast A
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD009687. PubMed ID: 26915340
[TBL] [Abstract][Full Text] [Related]
31. Convalescent plasma for people with COVID-19: a living systematic review.
Iannizzi C; Chai KL; Piechotta V; Valk SJ; Kimber C; Monsef I; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Jindal A; Cryns N; Estcourt LJ; Kreuzberger N; Skoetz N
Cochrane Database Syst Rev; 2023 May; 5(5):CD013600. PubMed ID: 37162745
[TBL] [Abstract][Full Text] [Related]
32. Strategies for using topical corticosteroids in children and adults with eczema.
Lax SJ; Harvey J; Axon E; Howells L; Santer M; Ridd MJ; Lawton S; Langan S; Roberts A; Ahmed A; Muller I; Ming LC; Panda S; Chernyshov P; Carter B; Williams HC; Thomas KS; Chalmers JR
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013356. PubMed ID: 35275399
[TBL] [Abstract][Full Text] [Related]
33. Convalescent plasma for people with COVID-19: a living systematic review.
Iannizzi C; Chai KL; Piechotta V; Valk SJ; Kimber C; Monsef I; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Jindal A; Cryns N; Estcourt LJ; Kreuzberger N; Skoetz N
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013600. PubMed ID: 36734509
[TBL] [Abstract][Full Text] [Related]
34. Interventions for vitiligo.
Whitton ME; Pinart M; Batchelor J; Leonardi-Bee J; González U; Jiyad Z; Eleftheriadou V; Ezzedine K
Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD003263. PubMed ID: 25710794
[TBL] [Abstract][Full Text] [Related]
35. Remdesivir for the treatment of COVID-19.
Grundeis F; Ansems K; Dahms K; Thieme V; Metzendorf MI; Skoetz N; Benstoem C; Mikolajewska A; Griesel M; Fichtner F; Stegemann M
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014962. PubMed ID: 36695483
[TBL] [Abstract][Full Text] [Related]
36. Interventions for Old World cutaneous leishmaniasis.
Heras-Mosteiro J; Monge-Maillo B; Pinart M; Lopez Pereira P; Reveiz L; Garcia-Carrasco E; Campuzano Cuadrado P; Royuela A; Mendez Roman I; López-Vélez R
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD005067. PubMed ID: 29192424
[TBL] [Abstract][Full Text] [Related]
37. Interventions for Old World cutaneous leishmaniasis.
Heras-Mosteiro J; Monge-Maillo B; Pinart M; Lopez Pereira P; Reveiz L; Garcia-Carrasco E; Campuzano Cuadrado P; Royuela A; Mendez Roman I; López-Vélez R
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD005067. PubMed ID: 29149474
[TBL] [Abstract][Full Text] [Related]
38. Interventions for infantile seborrhoeic dermatitis (including cradle cap).
Victoire A; Magin P; Coughlan J; van Driel ML
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD011380. PubMed ID: 30828791
[TBL] [Abstract][Full Text] [Related]
39. Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
von Groote TC; Williams G; Au EH; Chen Y; Mathew AT; Hodson EM; Tunnicliffe DJ
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004293. PubMed ID: 34778952
[TBL] [Abstract][Full Text] [Related]
40. Ivermectin for preventing and treating COVID-19.
Popp M; Reis S; Schießer S; Hausinger RI; Stegemann M; Metzendorf MI; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD015017. PubMed ID: 35726131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
